Persistent URL of this record https://hdl.handle.net/1887/3184367
Documents
-
- Download
- 1-s2.0-S0264410X20309476-main
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial
- All authors
- Verdijk, P.; Plas, J.L. van der; Brummelen, E.M.J. van; Jeeninga, R.E.; Haan, C.A.M. de; Roestenberg, M.; Burggraaf, J.; Kamerling, I.M.C.
- Date
- 2020-09-03
- Journal
- Vaccine
- Volume
- 38
- Issue
- 39
- Pages
- 6088 - 6095